Pioglitazone and metformin are equally effective in reduction of chemerin in patients with type 2 diabetes.

J Diabetes Investig · 2014 · PMC4020338 · PMID 24843782

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Systolic blood pressure of the pioglitazone group patients was slightly higher; however, this difference did not reach statistical significance (mean difference 5.12 mmHg, 95% confidence interval −10.35 to 0.10).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.